Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?
We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithy...
Gespeichert in:
Veröffentlicht in: | Movement disorders 1996-09, Vol.11 (5), p.555-562 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 562 |
---|---|
container_issue | 5 |
container_start_page | 555 |
container_title | Movement disorders |
container_volume | 11 |
creator | Ghika-Schmid, F. Ghika, J. Regli, F. Dworak, N. Bogousslavsky, J. Städler, C. Portmann, L. Despland, P. A. |
description | We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity. |
doi_str_mv | 10.1002/mds.870110511 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78451029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78451029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</originalsourceid><addsrcrecordid>eNp90MFu1DAQBmALgcpSOHJEygHBKcUTJ7bDpapaaBELHCjq0Zo4Y9aQ2IudFezbk2qjFSckSz7M5_HMz9hz4GfAefVm7POZVhyANwAP2AoaAaWuGvWQrbjWTSlAN4_Zk5x_8Fk1IE_YidZS1q1asfUN5o0f4xRf52LcRzvE4G1BwdJ2g0Pc4rTZvy0uQrELPaXe4_cQM_XFlAgn7AYqbAy9n3wM50_ZI4dDpmfLfcq-vX93e3lTrr9cf7i8WJe2li2UKFqnBfBWik4QuZ4a7hQKJ1rsKpBWVU4oW3eADnmtRF3hvFAtUdUzI3HKXh36blP8taM8mdFnS8OAgeIuG6XrBnjVzrA8QJtizomc2SY_Ytob4OY-PTOnZ47pzf7F0njXjdQf9RLXXH-51DFbHFzCYH0-MlHx-dwzdWC__UD7__9pPl19_XeAZWCfJ_pzfInpp5FKqMbcfb42a5C3oK7uzEfxF1CDlug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78451029</pqid></control><display><type>article</type><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</creator><creatorcontrib>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</creatorcontrib><description>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.870110511</identifier><identifier>PMID: 8866497</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Anti-Inflammatory Agents - administration & dosage ; Anti-Inflammatory Agents - therapeutic use ; Anticonvulsants - administration & dosage ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Brain - physiopathology ; Clonazepam - administration & dosage ; Clonazepam - therapeutic use ; Cognition Disorders - diagnosis ; Electroencephalography ; Extrapyramidal Tracts - physiopathology ; Female ; Frontal Lobe - physiopathology ; Hashimoto's myoclonic encephalopathy ; Humans ; Medical sciences ; Methylprednisolone - administration & dosage ; Methylprednisolone - therapeutic use ; Myoclonus - drug therapy ; Myoclonus - physiopathology ; Nervous system involvement in other diseases. Miscellaneous ; Neurology ; Neuropsychological Tests ; Prednisone - administration & dosage ; Prednisone - therapeutic use ; Subacute diffuse encephalopathy ; Temporal Lobe - physiopathology ; Thyroiditis ; Thyroiditis, Autoimmune - diagnosis ; Thyroiditis, Autoimmune - drug therapy ; Thyroiditis, Autoimmune - physiopathology ; Thyrotropin - secretion</subject><ispartof>Movement disorders, 1996-09, Vol.11 (5), p.555-562</ispartof><rights>Copyright © 1996 Movement Disorder Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</citedby><cites>FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.870110511$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.870110511$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,23909,23910,25118,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3203207$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8866497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghika-Schmid, F.</creatorcontrib><creatorcontrib>Ghika, J.</creatorcontrib><creatorcontrib>Regli, F.</creatorcontrib><creatorcontrib>Dworak, N.</creatorcontrib><creatorcontrib>Bogousslavsky, J.</creatorcontrib><creatorcontrib>Städler, C.</creatorcontrib><creatorcontrib>Portmann, L.</creatorcontrib><creatorcontrib>Despland, P. A.</creatorcontrib><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Inflammatory Agents - administration & dosage</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anticonvulsants - administration & dosage</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Brain - physiopathology</subject><subject>Clonazepam - administration & dosage</subject><subject>Clonazepam - therapeutic use</subject><subject>Cognition Disorders - diagnosis</subject><subject>Electroencephalography</subject><subject>Extrapyramidal Tracts - physiopathology</subject><subject>Female</subject><subject>Frontal Lobe - physiopathology</subject><subject>Hashimoto's myoclonic encephalopathy</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Methylprednisolone - administration & dosage</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Myoclonus - drug therapy</subject><subject>Myoclonus - physiopathology</subject><subject>Nervous system involvement in other diseases. Miscellaneous</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Prednisone - administration & dosage</subject><subject>Prednisone - therapeutic use</subject><subject>Subacute diffuse encephalopathy</subject><subject>Temporal Lobe - physiopathology</subject><subject>Thyroiditis</subject><subject>Thyroiditis, Autoimmune - diagnosis</subject><subject>Thyroiditis, Autoimmune - drug therapy</subject><subject>Thyroiditis, Autoimmune - physiopathology</subject><subject>Thyrotropin - secretion</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90MFu1DAQBmALgcpSOHJEygHBKcUTJ7bDpapaaBELHCjq0Zo4Y9aQ2IudFezbk2qjFSckSz7M5_HMz9hz4GfAefVm7POZVhyANwAP2AoaAaWuGvWQrbjWTSlAN4_Zk5x_8Fk1IE_YidZS1q1asfUN5o0f4xRf52LcRzvE4G1BwdJ2g0Pc4rTZvy0uQrELPaXe4_cQM_XFlAgn7AYqbAy9n3wM50_ZI4dDpmfLfcq-vX93e3lTrr9cf7i8WJe2li2UKFqnBfBWik4QuZ4a7hQKJ1rsKpBWVU4oW3eADnmtRF3hvFAtUdUzI3HKXh36blP8taM8mdFnS8OAgeIuG6XrBnjVzrA8QJtizomc2SY_Ytob4OY-PTOnZ47pzf7F0njXjdQf9RLXXH-51DFbHFzCYH0-MlHx-dwzdWC__UD7__9pPl19_XeAZWCfJ_pzfInpp5FKqMbcfb42a5C3oK7uzEfxF1CDlug</recordid><startdate>199609</startdate><enddate>199609</enddate><creator>Ghika-Schmid, F.</creator><creator>Ghika, J.</creator><creator>Regli, F.</creator><creator>Dworak, N.</creator><creator>Bogousslavsky, J.</creator><creator>Städler, C.</creator><creator>Portmann, L.</creator><creator>Despland, P. A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>199609</creationdate><title>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</title><author>Ghika-Schmid, F. ; Ghika, J. ; Regli, F. ; Dworak, N. ; Bogousslavsky, J. ; Städler, C. ; Portmann, L. ; Despland, P. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4691-a39f8310963b3eefde50f7a3f39ab216c72f37c4b1afa047342a82546a747a3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Inflammatory Agents - administration & dosage</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anticonvulsants - administration & dosage</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Brain - physiopathology</topic><topic>Clonazepam - administration & dosage</topic><topic>Clonazepam - therapeutic use</topic><topic>Cognition Disorders - diagnosis</topic><topic>Electroencephalography</topic><topic>Extrapyramidal Tracts - physiopathology</topic><topic>Female</topic><topic>Frontal Lobe - physiopathology</topic><topic>Hashimoto's myoclonic encephalopathy</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Methylprednisolone - administration & dosage</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Myoclonus - drug therapy</topic><topic>Myoclonus - physiopathology</topic><topic>Nervous system involvement in other diseases. Miscellaneous</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Prednisone - administration & dosage</topic><topic>Prednisone - therapeutic use</topic><topic>Subacute diffuse encephalopathy</topic><topic>Temporal Lobe - physiopathology</topic><topic>Thyroiditis</topic><topic>Thyroiditis, Autoimmune - diagnosis</topic><topic>Thyroiditis, Autoimmune - drug therapy</topic><topic>Thyroiditis, Autoimmune - physiopathology</topic><topic>Thyrotropin - secretion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghika-Schmid, F.</creatorcontrib><creatorcontrib>Ghika, J.</creatorcontrib><creatorcontrib>Regli, F.</creatorcontrib><creatorcontrib>Dworak, N.</creatorcontrib><creatorcontrib>Bogousslavsky, J.</creatorcontrib><creatorcontrib>Städler, C.</creatorcontrib><creatorcontrib>Portmann, L.</creatorcontrib><creatorcontrib>Despland, P. A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghika-Schmid, F.</au><au>Ghika, J.</au><au>Regli, F.</au><au>Dworak, N.</au><au>Bogousslavsky, J.</au><au>Städler, C.</au><au>Portmann, L.</au><au>Despland, P. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition?</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>1996-09</date><risdate>1996</risdate><volume>11</volume><issue>5</issue><spage>555</spage><epage>562</epage><pages>555-562</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>We report two patients with subacute diffuse encephalopathy characterized by confusion, myoclonic encephalopathy, and mild akineto‐rigid extrapyramidal signs in one case and by apathy, memory deficit, and partial complex seizures in the other. Hashimoto's thyroiditis with high titers of antithyroglobulin antibodies was diagnosed in both patients, who were unresponsive to anticonvulsant medication, but showed rapid neurological improvement following steroid treatment. On neuropsychological examination, predominant frontotemporal dysfunction was noted. Electroencephalographic activity was remarkable for its rhythmical delta activity, unresponsive to, or even paradoxically increased by, anticonvulsant treatment. On magnetic resonance imaging, atrophy with temporal predominance was found. These observations support the idea that this potentially treatable dementia and movement disorder should be classified as a separate clinical entity.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8866497</pmid><doi>10.1002/mds.870110511</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3185 |
ispartof | Movement disorders, 1996-09, Vol.11 (5), p.555-562 |
issn | 0885-3185 1531-8257 |
language | eng |
recordid | cdi_proquest_miscellaneous_78451029 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult Aged Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - therapeutic use Anticonvulsants - administration & dosage Anticonvulsants - therapeutic use Biological and medical sciences Brain - physiopathology Clonazepam - administration & dosage Clonazepam - therapeutic use Cognition Disorders - diagnosis Electroencephalography Extrapyramidal Tracts - physiopathology Female Frontal Lobe - physiopathology Hashimoto's myoclonic encephalopathy Humans Medical sciences Methylprednisolone - administration & dosage Methylprednisolone - therapeutic use Myoclonus - drug therapy Myoclonus - physiopathology Nervous system involvement in other diseases. Miscellaneous Neurology Neuropsychological Tests Prednisone - administration & dosage Prednisone - therapeutic use Subacute diffuse encephalopathy Temporal Lobe - physiopathology Thyroiditis Thyroiditis, Autoimmune - diagnosis Thyroiditis, Autoimmune - drug therapy Thyroiditis, Autoimmune - physiopathology Thyrotropin - secretion |
title | Hashimoto's myoclonic encephalopathy: An underdiagnosed treatable condition? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T11%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hashimoto's%20myoclonic%20encephalopathy:%20An%20underdiagnosed%20treatable%20condition?&rft.jtitle=Movement%20disorders&rft.au=Ghika-Schmid,%20F.&rft.date=1996-09&rft.volume=11&rft.issue=5&rft.spage=555&rft.epage=562&rft.pages=555-562&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.870110511&rft_dat=%3Cproquest_cross%3E78451029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78451029&rft_id=info:pmid/8866497&rfr_iscdi=true |